{
    "clinical_study": {
        "@rank": "127728", 
        "arm_group": [
            {
                "arm_group_label": "032-11", 
                "arm_group_type": "Experimental", 
                "description": "032-11 topical haemostat."
            }, 
            {
                "arm_group_label": "Floseal (R)", 
                "arm_group_type": "Active Comparator", 
                "description": "Floseal(R) topical haemostat"
            }
        ], 
        "brief_summary": {
            "textblock": "The effectiveness objective of this study is to evaluate whether 032-11 is non-inferior to\n      Floseal as an adjunct to achieving haemostasis during surgical procedures involving cardiac\n      and aortic thoracic surgery."
        }, 
        "brief_title": "Safety and Performance of 032-11 Haemostat in Cardiac and Thoracic Aortic Surgery", 
        "condition": [
            "C.Surgical Procedure; Cardiac", 
            "Haemorrhage."
        ], 
        "condition_browse": {
            "mesh_term": "Hemorrhage"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  The patient must be equal or greater than 18 years old\n\n          -  The patient must have elective or non-elective urgent cardiac surgery or thoracic\n             aortic surgery\n\n          -  The patient must have no childbearing potential or have a negative serum or urine\n             pregnancy test within 7 days of the planned surgery or in the opinion of the\n             Investigator performs adequate contraception\n\n          -  The patient is willing and able to be contacted for the follow-up visit at 6- 8 weeks\n\n          -  The patient must provide written informed consent using a form that is reviewed and\n             approved by the IEC\n\n        Exclusion Criteria:\n\n          -  The patient is currently enrolled in this or another investigational device or drug\n             trial that has not completed the required follow up period.\n\n          -  The patient has a known hypersensitivity to materials of bovine origin\n\n          -  The patient does not wish to receive materials of bovine or shellfish origin for any\n             reason"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 13, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01879475", 
            "org_study_id": "CT001"
        }, 
        "intervention": [
            {
                "arm_group_label": "032-11", 
                "description": "Topical haemostat", 
                "intervention_name": "032-11", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Floseal (R)", 
                "description": "Topical haemostat", 
                "intervention_name": "Floseal (R)", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "June 13, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Hull", 
                    "country": "United Kingdom", 
                    "state": "East Yorkshire", 
                    "zip": "HU3 2JZ"
                }, 
                "name": "Hull and East Yorkshire Hospitals NHS Trust"
            }, 
            "investigator": {
                "last_name": "Mahmoud Loubani, FRCS", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_arms": "2", 
        "official_title": "Prospective, Randomised, Controlled Investigation Comparing the Safety and Performance of 032-11 Surgical Haemostat With FLOSEAL\u00ae Haemostatic Matrix in Cardiac Surgery and Thoracic Aortic Surgery.", 
        "overall_contact": {
            "email": "saraandpete.farmer@virgin.net", 
            "last_name": "Sara Farmer", 
            "phone": "+44 1270 500 019"
        }, 
        "overall_contact_backup": {
            "email": "june.gladman@medtrade.co.uk", 
            "last_name": "June Gladman, PhD", 
            "phone": "+44 1270 500 019"
        }, 
        "overall_official": {
            "affiliation": "Blackpool Victoria Hospital NHS trust", 
            "last_name": "Russell Millner, MD FRCS", 
            "role": "Study Chair"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United Kingdom: Medicines and Healthcare Products Regulatory Agency", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Proportion of patients achieving haemostasis success following the first application of compression.", 
            "measure": "Haemostasis success", 
            "safety_issue": "No", 
            "time_frame": "Intra-operative"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01879475"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Medtrade", 
        "sponsors": {
            "collaborator": {
                "agency": "The Clinical Trial Company, Knutsford, United Kingdom", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Medtrade", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}